As cell research has shown, Epithalon interacts directly with DNA with the promoter regions of CD5, IL-2, MMP2 and Tram1 genes and increases their expression
Numerous clinical trials are underway investigating obesity assets in co-morbidities, e.g., MACE-3 components, heart failure, sleep apnea, chronic kidney disease (CKD), NASH/MASH, osteoarthritis of knee, with several recent positive, high-profile readouts, including semaglutide in CKD and HFpEF
Older teens and men respond well to low dose phentermine or Tenuate, especially when the dosing is early in the morning and only once a day
Not suitable for everyone : GLP-1 may not be appropriate for individuals with certain medical conditions or those taking specific medications